4-((2-Chlorophenyl)diazenyl)-3-hydroxy-N-phenyl-2-naphthamide

Catalog No. :
ACASFB334
CAS No. :
6410-26-0
Molecular Formula :
C23H16ClN3O2
Molecular Weight :
401.85

IUPAC Name:(E)-4-((2-chlorophenyl)diazenyl)-3-hydroxy-N-phenyl-2-naphthamide

4-((2-Chlorophenyl)diazenyl)-3-hydroxy-N-phenyl-2-naphthamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%$159.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-((2-Chlorophenyl)diazenyl)-3-hydroxy-N-phenyl-2-naphthamide
IUPAC Name(E)-4-((2-chlorophenyl)diazenyl)-3-hydroxy-N-phenyl-2-naphthamide
MDL No.MFCD00517153
Molecular FormulaC23H16ClN3O2
Molecular Weight401.85
SMILESO=C(NC1=CC=CC=C1)C1=C(O)C(/N=N/C2=CC=CC=C2Cl)=C2C=CC=CC2=C1
InChI KeyXNANGTRPTFPPPE-CYYJNZCTSA-N
Synonym2-Naphthalenecarboxamide,4-[(2-chlorophenyl)azo]-3-hydroxy-N-phenyl- | 2-Naphthalenecarboxamide, 4-[(2-chlorophenyl)azo]-3-hydroxy-N-phenyl- | 4-((2-Chlorophenyl)diazenyl)-3-hydroxy-N-phenyl-2-naphthamide | 4-[(2-chlorophenyl)azo]-3-hydroxy-N-phenylnaphth
CAS No.6410-26-0
PubChem CID80854

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364

Synthetic Route by SureRoute

1. ACASFB334 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACASFB334 route product structure diagram
    ACASFB3346410-26-0
Inquiry

2. ACASFB334 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACASFB334 route product structure diagram
    ACASFB3346410-26-0
Inquiry

Comments (0)